These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Sirohi B, Powles R, Treleaven J, Mainwaring P, Kulkarni S, Pandha H, Bhagwati N, Horton C, Singhal S, Mehta J. Bone Marrow Transplant; 2000 Mar; 25(5):533-9. PubMed ID: 10713631 [Abstract] [Full Text] [Related]
44. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma. Dyson PG, Horvath N, Joshua D, Barrow L, Van Holst NG, Brown R, Gibson J, To LB. Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530 [Abstract] [Full Text] [Related]
48. [Middle-high dose of cyclophosphamide or conventional routine chemotherapy with increased dose of cyclophosphamide combined with G-CSF for mobilizing peripheral blood progenitor cells in patients with tumor]. Lu DP, Liu KY, Guo NL, Shi YK, He XH, Lou FD, Da WM, Zhang BL, Wang LX, Ke XY. Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):68-70. PubMed ID: 12697098 [Abstract] [Full Text] [Related]
49. DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients. Zappasodi P, Nosari AM, Astori C, Ciapanna D, Bonfichi M, Varettoni M, Mangiacavalli S, Morra E, Lazzarino M, Corso A. Transfusion; 2008 May; 48(5):857-60. PubMed ID: 18248573 [Abstract] [Full Text] [Related]
51. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim. Damon L, Rugo H, Tolaney S, Navarro W, Martin T, Ries C, Case D, Ault K, Linker C. Biol Blood Marrow Transplant; 2006 Mar; 12(3):316-24. PubMed ID: 16503501 [Abstract] [Full Text] [Related]
56. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. López-Pérez R, García-Sanz R, González D, Balanzategui A, Chillón MC, Alaejos I, Mateos MV, Caballero MD, Corral M, Orfão A, González M, San Miguel JF. Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789 [Abstract] [Full Text] [Related]
57. The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma. Hiwase DK, Hiwase S, Bailey M, Bollard G, Schwarer AP. Cytotherapy; 2008 Oct; 10(5):507-17. PubMed ID: 18608354 [Abstract] [Full Text] [Related]